Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial

Ítems similars

• Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer
  per: Breyer, Benjamin N., et al.
  Publicat: (2009)
• Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer
  per: Lightfoot, Andrew J., et al.
  Publicat: (2013)
• Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
  per: Steinberg, Ryan L., et al.
  Publicat: (2015)
• Bladder Tissue Pharmacokinetics of Intravesical Mitomycin C and Suramin in Dogs
  per: Hu, Leijun, et al.
  Publicat: (2010)
• Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
  per: Milbar, Niv, et al.
  Publicat: (2017)